Sign in Subscribe
Biological products industry

Ardian Acquires Majority Stake in Masco Group, A Global Provider of Engineered Solutions

Strategic Insights

— 1 min read

Ardian, a world-leading private investment house, has acquired a majority stake in Masco Group, a global provider of engineered solutions for the pharmaceutical and biotech industries. Founded in 1912 and headquartered in Milan, Masco provides high-purity water systems, bioprocessing equipment, and modular off-site fabricated facility solutions to the biopharma and life sciences industry.

Key Takeaways:

  • Ardian has acquired a majority stake in Masco Group, a global provider of engineered solutions for the pharmaceutical and biotech industries.
  • Masco Group was founded in 1912 and is headquartered in Milan, Italy.
  • The company provides high-purity water systems, bioprocessing equipment, and modular off-site fabricated facility solutions to the biopharma and life sciences industry.
  • Masco's customers include the world's largest biopharma companies and CDMOs, with international sales in more than 80 countries.
  • The company has 7 manufacturing facilities located across Europe, North America, and Asia, and has revenue in excess of €300m and more than 800 employees.
  • Luca Borella will continue to lead the company as CEO, and Angelos Papadimitriou and Claudio Colombi will join the Board of Directors as Chairman and Director, respectively.
  • Ardian will leverage its deep industry expertise in pharmaceutical and life sciences to support Masco in the next phase of growth, driving a number of compelling organic initiatives, further international expansion, and completing acquisitions focused on strengthening the Company's technological capabilities while driving operational excellence.

Statistics:

  • Ardian's investment in Masco Group is a testament to its expertise in investing in the most attractive niches within healthcare and partnering with leading entrepreneurial families.
  • The transaction is valued at undisclosed amount.
  • Masco Group has revenue in excess of €300m and more than 800 employees.
  • The company has 7 manufacturing facilities located across Europe, North America, and Asia.
  • Ardian has acquired a majority stake in Masco Group, with the remaining stake held by the Borella family and Masco Group's current management team.

Sources:

  • Ardian [Category: Life Sciences, Pharmaceuticals, M&A Activities]
  • Masco Group [mascogroup.com]
  • RSBG SE/RAG-Stiftung [rsbg.com]

Read more